Depletion of Tregs in vivo: A promising approach to enhance antitumor immunity without autoimmunity

Immunotherapy

Volumn 4, Issue 11, 2012, Pages 1103-1105

  Morita, Rena ^a   Hirohashi, Yoshihiko ^a   Sato, Noriyuki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

anti CD25 antibody; daclizumab; immunotherapy; Treg

Indexed keywords

CANCER VACCINE; CD45RA ANTIGEN; DACLIZUMAB;

ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T CELL DEPLETION; TUMOR IMMUNITY;

EID: 84870444019     PISSN: 1750743X     EISSN: 17507448     Source Type: Journal    
DOI: 10.2217/imt.12.116     Document Type: Article

References (18)

1. Sakaguchi S, Yamaguchi T, Nomura T et al. Regulatory T cells and immune tolerance. Cell 133, 775-787 (2008).
2. Nishikawa H, Sakaguchi S. Regulatory T cells in tumor immunity. Int. J. Cancer 127, 759-767 (2010).
3. Jonuleit H, Schmitt E, Stassen M et al. Identification and functional characterization of human CD4+CD25+ T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 193, 1285-1294 (2001).
4. de Vries IJ, Castelli C, Huygens C et al. Frequency of circulating Tregs with demethylated FOXP3 intron 1 in melanoma patients receiving tumor vaccines and potentially Treg-depleting agents. Clin. Cancer Res. 17, 841-848 (2011).
5. Badoual C, Hans S, Rodriguez J et al. Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers. Clin. Cancer Res. 12, 465-472 (2006).
6. Petersen RP, Campa MJ, Sperlazza J et al. Tumor infiltrating Foxp3+ regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients. Cancer 107, 2866-2872 (2006).
7. Ichihara F, Kono K, Takahashi A et al. Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers. Clin. Cancer Res. 9, 4404-4408 (2003).
8. Wolf D, Wolf AM, Rumpold H et al. The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer. Clin. Cancer Res. 11, 8326-8331 (2005).
9. Kono K, Kawaida H, Takahashi A et al. CD4+CD25 high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers. Cancer Immunol. Immunother. 55, 1064-1071 (2006).
10. Viehl CT, Moore TT, Liyanage UK et al. Depletion of CD4+CD25+ regulatory T cells promotes a tumor-specific immune response in pancreas cancer-bearing mice. Ann. Surg. Oncol. 13, 1252-1258 (2006).
11. Rudge G, Barrett SP, Scott B et al. Infiltration of a mesothelioma by IFN-g-producing cells and tumor rejection after depletion of regulatory T cells. J. Immunol. 178, 4089-4096 (2007).
12. Maker AV, Attia P, Rosenberg SA. Analysis of the cellular mechanism of antitumor responses and autoimmunity in patients treated with CTLA-4 blockade. J. Immunol. 175, 7746-7754 (2005).
13. Vieweg J, Su Z, Dahm P et al. Reversal of tumor-mediated immunosuppression. Clin. Cancer Res. 13, 727S-732S (2007).
14. Jacobs JF, Punt CJ, Lesterhuis WJ et al. Dendritic cell vaccination in combination with anti-CD25 monoclonal antibody treatment: a Phase I/II study in metastatic melanoma patients. Clin. Cancer Res. 16, 5067-5078 (2010).
15. Rech AJ, Mick R, Martin S et al. CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patients. Sci. Transl. Med. 4(134), 134ra62 (2012).
16. Wuest SC, Edwan JH, Martin JF et al. A role for interleukin-2 trans-presentation in dendritic cell-mediated T cell activation in humans, as revealed by daclizumab therapy. Nat. Med. 17, 604-609 (2011).
17. Callahan MK, Wolchok JD, Allison JP. Anti-CTLA-4 antibody therapy: immune monitoring during clinical development of a novel immunotherapy. Semin. Oncol. 37, 473-484 (2010).
18. Hoffmann P, Eder R, Boeld TJ et al. Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion. Blood 108, 4260-4267 (2006).